ArticleFrontiers in pharmacology2026

GUDCA drives colorectal cancer progression via ALKBH5-mediated m6A modification of ENO1 and glycolytic reprogramming.

Ruirong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.